Clinical Trial Update: Apremilast and Adalimumab in Psoriatic Arthritis Patients [NA]

View source ↗

Summary

A clinical trial evaluating apremilast and adalimumab for psoriatic arthritis is not yet recruiting and includes ultrasound assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Humira (adalimumab)
• OTEZLA (apremilast)

Snippet

Sponsor: Tanta University | Conditions: Psoriatic Arthritis, Ultrasound Assessment | NA | Status: NOT_YET_RECRUITING